Custo de Mercadoria Vendida Alterar Data
AstraZeneca USD 2.52B 2.73B 2026-06
Genmab DKK 84M 19M 2026-06
GlaxoSmithKline GBP 2.07B 192M 2026-06
GRIFOLS EUR 1.17B 90M 2026-06
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Lakefront Biotherapeutics EUR 9.14M 4.35M 2026-06
Qiagen NV USD 196.45M 13.73M 2026-06
UCB EUR 1.07B 146M 2025-12